Titre : | Feasibility and outcome of HCV treatment in a Canadian federal prison population. (2005) |
Auteurs : | FARLEY (John) : CAN. University of British Columbia and John Farley. Inc. Vancouver. BC. ; FARLEY (Theresa-A) : CAN. John Farley. Inc. Vancouver. ; Benedikt Fischer ; Emma HAYDON ; REHM (Jürgen) : CHE. Addiction Research Institute. Zurich. ; VASDEV (Shawn) : CAN. University of Ottawa. Ottawa. ON. ; Centre for Addiction and Mental Health. Toronto. ON. CAN |
Type de document : | Article |
Dans : | American journal of public health (vol. 95, n° 10, 2005) |
Pagination : | 1737-1739 |
Langues: | Anglais |
Mots-clés : | Etude faisabilité ; Pronostic ; Thérapeutique ; Evolution ; VHC ; Virus ; Canada ; Amérique ; Politique santé ; Gouvernement ; Prison ; Hépatite virale C ; Virose ; Infection ; Thérapeutique médicamenteuse ; Chimiothérapie ; Médicament antiviral ; Appareil digestif [pathologie] ; Foie [pathologie] ; Amérique du Nord ; Détenu |
Résumé : | [BDSP. Notice produite par INIST-CNRS R0xegGOF. Diffusion soumise à autorisation]. We assessed feasibility and outcome of hepatitis C virus (HCV) treatment in male correctional inmates in British Columbia, Canada. We reviewed the medical charts of 114 treated inmates ; 80 had complete data for treatment outcome. Approximately 4 of 5 inmates completed treatment (78.8%) ; 66.3% achieved sustained virological response. Those who completed treatment, those with injection drug use as a risk factor, and those with genotypes 2 and 3 were significantly more likely to achieve sustained virological response. HCV treatment in correctional inmates is feasible and effective. |